News
Rule Breaker Investing Mailbag: Spiffy-Pop and a Rocket Stock
A listener uses Rule Breaker tactics, keeps adding as the stock climbs, and lands their first spiffy-pop. Motley Fool co-founder David Gardner retells the term's origin and brings back analyst
Aflac (AFL) EPS Beats Sales Drop 19%
Aflac (NYSE:AFL), a leading provider of supplemental health and life insurance in the U.S. and Japan, reported its Q2 2025 earnings on August 5, 2025. The company reported adjusted earnings per
Reddit Stock Analysis: Buy or Sell?
Reddit (NYSE: RDDT) reported phenomenal increases in revenue and profitability in its most recent quarterly financial update.
*Stock prices used were the afternoon prices of Aug. 3, 2025. The video
SIGA (SIGA) Q2 Revenue Soars 272%
SIGA Technologies (NASDAQ:SIGA), a pharmaceutical company known for its antiviral therapies used in biodefense, posted second quarter fiscal 2025 financial results on August 5, 2025. The most
UnitedHealth Stock Investors: You Need to Know This Before Buying or Selling This Stock
UnitedHealth Group (NYSE: UNH) stock investors will want to digest this information before making the important decision to invest in or divest from this stock.
*Stock prices used were the
Cullen Frost (CFR) Q2 2025 Earnings Transcript
Image source: The Motley Fool.
Thursday, July 31, 2025, at 2 p.m. ET
Need a quote from one of our analysts? Email [email protected]
Source Fool.com
Claritev (CTEV) Q2 Revenue Rises 4%
Claritev (NYSE:CTEV), a healthcare data analytics and cost management company, reported its second quarter 2025 earnings on August 6, 2025. The standout news is revenue rising to $241.6 million
3 No-Brainer Artificial Intelligence (AI) Stocks to Buy Right Now
Wall Street is in the throes of earnings season, with the world's top businesses checking in at the halfway point of 2025. It's a crucial time for investors. There have been virtually no signs of
Why Is Everyone Talking About Novo Nordisk Stock?
The pharma giant is facing stiff competition that is hurting sales of its weight loss and diabetes treatments.
*Stock prices used were the afternoon prices of Aug. 3, 2025. The video was published
Geron (GERN) Q2 Revenue Jumps 5,477%
Geron (NASDAQ:GERN), a biotechnology company focused on therapies for blood disorders, released its second quarter 2025 results on August 6, 2025. The headline news was a sharp acceleration in
Werner (WERN) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Tuesday, July 29, 2025, at 5 p.m. ET
Need a quote from one of our analysts? Email [email protected]
Source Fool.com
EQS-News: freenet exceeds expectations for free cash flow – customer base and service revenues continue to grow, guidance for adjusted EBITDA and free cash flow confirmed
Should Investors Buy Palantir Stock?
Palantir (NASDAQ: PLTR) keeps surprising investors with its phenomenal growth across all critical performance metrics.
*Stock prices used were the afternoon prices of Aug. 3, 2025. The video was
Jazz (JAZZ) Q2 Revenue Rises 2%
Jazz Pharmaceuticals (NASDAQ:JAZZ) is a global biopharmaceutical company focused on innovative therapies for neuroscience and rare oncology diseases. On August 5, 2025, it reported second quarter
41 States That Don't Tax Social Security Benefits
Taxes are virtually impossible to avoid in modern American life. There are taxes on income, purchases, property, and even Social Security benefits. Paying taxes doesn't necessarily leave people
These Were the 2 Best-Performing Stocks in the Nasdaq-100 in July 2025
Last month was another solid one for the Nasdaq-100 index. All told, it advanced by 3.3%, bolstering the index's excellent year-to-date performance of 8.3%. However, some stocks significantly
Ultra Clean (UCTT) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Monday, July 28, 2025, 4:45 p.m. ET
Need a quote from one of our analysts? Email [email protected]
Source Fool.com
Tariffs and Trade Wars Can't Slow Big Tech's Momentum
In this podcast, Motley Fool contributors Lou Whiteman, Rachel Warren, and Jon Quast discuss:
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. When you're
ODP (ODP) Fiscal Q2 EPS Jumps 42%
ODP (NASDAQ:ODP), the office supply and business solutions company behind Office Depot and OfficeMax, reported its fiscal Q2 2025 earnings on August 6, 2025. The headline news is that adjusted
Spyre (SYRE) Q2 R&D Up 23% Loss Narrows
Spyre Therapeutics (NASDAQ:SYRE), a clinical-stage biotechnology company focused on antibody therapies for inflammatory diseases, released its second quarter results on August 5, 2025. Notably, Q2
This Company Looks Like a Dividend Champion in the Making and It Could Announce Another Dividend Hike Next Month
Finding a company that can consistently increase its dividend year after year is the ultimate investment for many. But established dividend payers can often provide shareholders with nominal raises
Massive News for UnitedHealth Stock Investors
The healthcare giant is experiencing one of its most challenging years in a very long time.
*Stock prices used were the afternoon prices of Aug. 2, 2025. The video was published on Aug. 4, 2025.
Bankwell (BWFG) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Monday, July 28, 2025, at 11 a.m. ET
Need a quote from one of our analysts? Email [email protected]
Source Fool.com
National Vision (EYE) Sales Jump 8%
National Vision (NASDAQ:EYE), a major value-focused optical retailer, released its results for the fiscal second quarter ended June 29, 2025, on August 6, 2025. It delivered GAAP revenue and
The Fed's Inflation Conundrum & an AI Billionaire Battle Royale
In this podcast, Motley Fool analyst Jason Moser and contributors Travis Hoium and Lou Whiteman discuss:
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center